Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Drug Discovery & Development
Zika Virus Tested as an Effective Oncolytic Agent for Glioblastoma in In Vitro Models
More results are in for the oncolytic potential of the Zika virus, where it has proven effective against the most common form of brain cancer in vitro.
Gene Therapy Development
Post-Event Proceedings – Gene Therapy Development & Manufacturing 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Gene Therapy Development & Manufacturing 2023.
Drug Discovery & Development
Post-Event Proceedings – Immuno 2023
Concise and insightful summaries of presentations delivered by prominent thought leaders at Immuno 2023.
eBook: Sustainability & Green Innovations in Pharma and Healthcare
Read how innovators are transforming the industry towards one that prioritizes both healthy patients and a healthy planet.
.png)
Spotlight On: Lindsay Davies, Chief Scientific Officer of NextCell Pharma
We caught up with Lindsay Davies, Chief Scientific Officer of NextCell Pharma, to hear about to hear about the latest advancements in stromal cell therapy in anticipation of her presentation at our Cell & Gene 2024 Congress this November.
Tumour Microenvironment
Decoding the Language of Tumor Immune Microenvironment: A Deep Dive into Spatial Biology Techniques
Immuno by Oxford Global will delve into the fascinating world of spatial biology techniques and their role in decoding the language of the tumour immune microenvironment.
Immunotherapy (Non-Oncology)
Uncovering Mechanisms of Immunotherapy Response & Resistance with Single Cell & Spatial Multiomics
Discover how 10x Genomics' spatial technologies are revolutionising the study of immunotherapies in solid tumors
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Preserving Life's Potential: methods and conditions of cryopreservation
Cryopreservation is a key technology in medicine, biotechnology, and conservation, enabling the preservation of biological materials at ultra-low temperatures for future use. It supports medical treatments, scientific research, and species conservation by maintaining the genetic integrity of cells, tissues, and organs. Cell & Gene by Oxford Global explores its mechanisms, methodologies, applications, and the future directions this essential technology is headed towards.
Immunotherapy (Non-Oncology)
Balancing Innovation and Ethics: The Role of Regulation in Microbiome-Based Precision Oncology
Microbiome-based precision oncology offers promising cancer treatment possibilities but requires clear regulations due to ethical concerns like patient safety and access. Collaboration among stakeholders is essential to balance innovation and ethics effectively.
Antibody & Protein Engineering
The Current Landscape of ADC Approvals and Market Trends: Q&A With Mahendra Deonarain, CEO of Antikor Biopharma
While a recent spike in ADC approvals may not last forever, Antikor Biopharma’s Mahendra Deonarain asserts that antibody-drug conjugates are here to stay.
Manufacturing & Bioprocessing
In Conversation With… Sophie Mountcastle, Network Manager, Innovation Hubs for Gene Therapies
Here, we discuss the crucial role of a collaborative network for gene therapy development across the UK and some of the successes seen to date.